首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Efficacy of Traditional Chinese Medicine Tonifying Kidney (Bushen) and Activating Blood (Huoxue) Prescription for Premature Ovarian Insufficiency: A Systematic Review and Meta-Analysis
【24h】

Efficacy of Traditional Chinese Medicine Tonifying Kidney (Bushen) and Activating Blood (Huoxue) Prescription for Premature Ovarian Insufficiency: A Systematic Review and Meta-Analysis

机译:中药调整肾(丛林)和激活血液(Huoxue)处方对早过早的卵巢功能不足的疗效:系统审查和荟萃分析

获取原文
           

摘要

Context. Premature ovarian insufficiency (POI) is one of the difficult gynecological diseases with complex etiologies. Tonifying kidney (bushen) and activating blood (huoxue) prescription (TKABP) is a popular traditional Chinese medicine (TCM) therapy which is commonly applied for POI. However, its efficacy and safety are still controversial. Objective. We carried out this systematic review and meta-analysis to evaluate the effectiveness of TKABP on POI. Methods. The following eight databases were searched from the establishment to September 30, 2019, for randomized controlled trials (RCTs): PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure (CNKI), the Chinese BioMedical database (CBM), Chinese Scientific Journal Database (VIP), and the Wanfang database. The quality of evidence was estimated by the Grading of Recommendations Assessment, Development, and Evaluation (GRADE). Results. Twenty-three RCTs involving 1712 patients with POI were included. Compared to hormone therapy (HT) groups, TKABP groups showed a significantly higher total effective rate (RR: 1.10; 95% CI: 1.04–1.17; P0.01, I2?=?32%). In addition, TKABP groups revealed a better improvement in terms of serum follicle-stimulating hormone (FSH) levels, serum estradiol (E2) levels, peak systolic velocity (PSV) of ovarian stromal blood, and Kupperman index (KI) score. However, serum luteinizing hormone (LH) levels and ovarian volume (OV) showed no significant statistical difference. Subgroup analyses showed that herbal paste and 3?months of treatment duration had a greater effect on the improvement of hormone levels. Besides, the occurrence of related adverse events in TKABP groups was lower than that in HT groups. Conclusions. Our review suggests that TKABP appears to be an effective and safe measure for patients with POI, and the herbal paste may be superior. However, the methodological quality of included RCTs was unsatisfactory, and it is necessary to verify its effectiveness with furthermore standardized researches of rigorous design.
机译:语境。过早的卵巢不足(POI)是具有复杂病因的困难的妇科疾病之一。调整肾(丛林)和活化血液(Huoxue)处方(TKABP)是一种普遍应用于POI的受欢迎的中医(TCM)治疗。然而,它的功效和安全仍然存在争议。客观的。我们开展了这一系统审查和荟萃分析,以评估TKABP对POI的有效性。方法。在2019年9月30日的建立中,为随机对照试验(RCT),搜索了以下八个数据库:PubMed,Embase,Cochrane图书馆,科学网,中国国家知识基础设施(CNKI),中国生物医学数据库(CBM),中国科学期刊数据库(VIP)和Wanfang数据库。通过建议评估,发展和评估(成绩)的评分估计证据质量。结果。包括二十三个RCT,涉及1712名POI患者。与激素治疗(HT)组相比,TKABP基团显示出显着较高的总有效率(RR:1.10; 95%CI:1.04-1.17; P <0.01,I2?= 32%)。此外,TKABP组揭示了血清卵泡刺激激素(FSH)水平,血清雌二醇(E2)水平,卵巢基质血液和库普曼指数(Ki)评分的血清雌二醇(E2)水平,峰收缩速度(PSV)。然而,血清酸性激素(LH)水平和卵巢体积(OV)显示出没有显着的统计差异。亚组分析表明,草药糊和3个月的治疗持续时间对激素水平的改善具有更大的影响。此外,TKABP组中相关不良事件的发生低于HT组的发生。结论。我们的评论表明,TKABP似乎是对POI患者有效和安全的措施,草药糊可能是优越的。然而,包括RCT的方法论质量不令人满意,有必要验证其具有严格设计的标准化研究的有效性。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号